Market Analysis and Insights: Global Opioid Induced Constipation (OIC) Drugs Market
The global Opioid Induced Constipation (OIC) Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
Global Opioid Induced Constipation (OIC) Drugs Scope and Segment
The global Opioid Induced Constipation (OIC) Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Opioid Induced Constipation (OIC) Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.
The major regions covered in the report are North America, Europe, Asia-Pacific, South America, Middle East & Africa, etc. The report has specifically covered major countries including U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. It includes revenue and volume analysis of each region and their respective countries for the forecast years. It also contains country-wise volume and revenue from the year 2016 to 2021. Additionally, it provides the reader with accurate data on volume sales according to the consumption for the same years.
By the product type, the market is primarily split into
Lubiprostone
Methyl Naltrexone Bromide
Naldemedine
Alvimopan
Others
By the end users/application, this report covers the following segments
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Competitive Landscape:
The report provides a list of all the key players in the Opioid Induced Constipation (OIC) Drugs market along with a detailed analysis of the strategies, which the companies are adopting. The strategies mainly include new product Developments, research, and Developments, and also provides revenue shares, company overview, and recent company Developments to remain competitive in the market.
The Opioid Induced Constipation (OIC) Drugs key manufacturers in this market include:
Ironwood Pharmaceuticals Inc
Daiichi Sankyo Co Ltd
Pfizer
Progenics Pharmaceuticals Inc
Shionogi & Co., Ltd
Allergan Plc
Nektar Therapeutics
Purdue Pharma
S.L.A. Pharma AG
Mundipharma International Limited
Ono Pharmaceutical Co., Ltd
Takeda Pharmaceutical Company Limited
Theravance Biopharma Inc
Bausch Health
Cosmo Pharmaceuticals SA
Daewoong Pharmaceutical
C.B. Fleet Company
Sucampo Pharmaceuticals
The global Opioid Induced Constipation (OIC) Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
Global Opioid Induced Constipation (OIC) Drugs Scope and Segment
The global Opioid Induced Constipation (OIC) Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Opioid Induced Constipation (OIC) Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.
The major regions covered in the report are North America, Europe, Asia-Pacific, South America, Middle East & Africa, etc. The report has specifically covered major countries including U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. It includes revenue and volume analysis of each region and their respective countries for the forecast years. It also contains country-wise volume and revenue from the year 2016 to 2021. Additionally, it provides the reader with accurate data on volume sales according to the consumption for the same years.
By the product type, the market is primarily split into
Lubiprostone
Methyl Naltrexone Bromide
Naldemedine
Alvimopan
Others
By the end users/application, this report covers the following segments
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Competitive Landscape:
The report provides a list of all the key players in the Opioid Induced Constipation (OIC) Drugs market along with a detailed analysis of the strategies, which the companies are adopting. The strategies mainly include new product Developments, research, and Developments, and also provides revenue shares, company overview, and recent company Developments to remain competitive in the market.
The Opioid Induced Constipation (OIC) Drugs key manufacturers in this market include:
Ironwood Pharmaceuticals Inc
Daiichi Sankyo Co Ltd
Pfizer
Progenics Pharmaceuticals Inc
Shionogi & Co., Ltd
Allergan Plc
Nektar Therapeutics
Purdue Pharma
S.L.A. Pharma AG
Mundipharma International Limited
Ono Pharmaceutical Co., Ltd
Takeda Pharmaceutical Company Limited
Theravance Biopharma Inc
Bausch Health
Cosmo Pharmaceuticals SA
Daewoong Pharmaceutical
C.B. Fleet Company
Sucampo Pharmaceuticals
1 Opioid Induced Constipation (OIC) Drugs Market Overview
1.1 Opioid Induced Constipation (OIC) Drugs Product Overview
1.2 Opioid Induced Constipation (OIC) Drugs Market Segment by Type
1.2.1 Lubiprostone
1.2.2 Methyl Naltrexone Bromide
1.2.3 Naldemedine
1.2.4 Alvimopan
1.2.5 Others
1.3 Global Opioid Induced Constipation (OIC) Drugs Market Size by Type
1.3.1 Global Opioid Induced Constipation (OIC) Drugs Market Size Overview by Type (2016-2027)
1.3.2 Global Opioid Induced Constipation (OIC) Drugs Historic Market Size Review by Type (2016-2021)
1.3.2.1 Global Opioid Induced Constipation (OIC) Drugs Sales Breakdown in Volume by Type (2016-2021)
1.3.2.2 Global Opioid Induced Constipation (OIC) Drugs Sales Breakdown in Value by Type (2016-2021)
1.3.2.3 Global Opioid Induced Constipation (OIC) Drugs Average Selling Price (ASP) by Type (2016-2021)
1.3.3 Global Opioid Induced Constipation (OIC) Drugs Forecasted Market Size by Type (2022-2027)
1.3.3.1 Global Opioid Induced Constipation (OIC) Drugs Sales Breakdown in Volume by Type (2022-2027)
1.3.3.2 Global Opioid Induced Constipation (OIC) Drugs Sales Breakdown in Value by Type (2022-2027)
1.3.3.3 Global Opioid Induced Constipation (OIC) Drugs Average Selling Price (ASP) by Type (2022-2027)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Opioid Induced Constipation (OIC) Drugs Sales Breakdown by Type (2016-2021)
1.4.2 Europe Opioid Induced Constipation (OIC) Drugs Sales Breakdown by Type (2016-2021)
1.4.3 Asia-Pacific Opioid Induced Constipation (OIC) Drugs Sales Breakdown by Type (2016-2021)
1.4.4 Latin America Opioid Induced Constipation (OIC) Drugs Sales Breakdown by Type (2016-2021)
1.4.5 Middle East and Africa Opioid Induced Constipation (OIC) Drugs Sales Breakdown by Type (2016-2021)
2 Global Opioid Induced Constipation (OIC) Drugs Market Competition by Company
2.1 Global Top Players by Opioid Induced Constipation (OIC) Drugs Sales (2016-2021)
2.2 Global Top Players by Opioid Induced Constipation (OIC) Drugs Revenue (2016-2021)
2.3 Global Top Players Opioid Induced Constipation (OIC) Drugs Price (2016-2021)
2.4 Global Top Manufacturers Opioid Induced Constipation (OIC) Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Opioid Induced Constipation (OIC) Drugs Market Competitive Situation and Trends
2.5.1 Opioid Induced Constipation (OIC) Drugs Market Concentration Rate (2016-2021)
2.5.2 Global 5 and 10 Largest Manufacturers by Opioid Induced Constipation (OIC) Drugs Sales and Revenue in 2020
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Opioid Induced Constipation (OIC) Drugs as of 2020)
2.7 Date of Key Manufacturers Enter into Opioid Induced Constipation (OIC) Drugs Market
2.8 Key Manufacturers Opioid Induced Constipation (OIC) Drugs Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Opioid Induced Constipation (OIC) Drugs Status and Outlook by Region
3.1 Global Opioid Induced Constipation (OIC) Drugs Market Size and CAGR by Region: 2016 VS 2021 VS 2026
3.2 Global Opioid Induced Constipation (OIC) Drugs Historic Market Size by Region
3.2.1 Global Opioid Induced Constipation (OIC) Drugs Sales in Volume by Region (2016-2021)
3.2.2 Global Opioid Induced Constipation (OIC) Drugs Sales in Value by Region (2016-2021)
3.2.3 Global Opioid Induced Constipation (OIC) Drugs Sales (Volume & Value) Price and Gross Margin (2016-2021)
3.3 Global Opioid Induced Constipation (OIC) Drugs Forecasted Market Size by Region
3.3.1 Global Opioid Induced Constipation (OIC) Drugs Sales in Volume by Region (2022-2027)
3.3.2 Global Opioid Induced Constipation (OIC) Drugs Sales in Value by Region (2022-2027)
3.3.3 Global Opioid Induced Constipation (OIC) Drugs Sales (Volume & Value), Price and Gross Margin (2022-2027)
4 Global Opioid Induced Constipation (OIC) Drugs by Application
4.1 Opioid Induced Constipation (OIC) Drugs Market Segment by Application
4.1.1 Hospital Pharmacies
4.1.2 Retail Pharmacies
4.1.3 Online Pharmacies
4.2 Global Opioid Induced Constipation (OIC) Drugs Market Size by Application
4.2.1 Global Opioid Induced Constipation (OIC) Drugs Market Size Overview by Application (2016-2027)
4.2.2 Global Opioid Induced Constipation (OIC) Drugs Historic Market Size Review by Application (2016-2021)
4.2.2.1 Global Opioid Induced Constipation (OIC) Drugs Sales Breakdown in Volume, by Application (2016-2021)
4.2.2.2 Global Opioid Induced Constipation (OIC) Drugs Sales Breakdown in Value, by Application (2016-2021)
4.2.2.3 Global Opioid Induced Constipation (OIC) Drugs Average Selling Price (ASP) by Application (2016-2021)
4.2.3 Global Opioid Induced Constipation (OIC) Drugs Forecasted Market Size by Application (2022-2027)
4.2.3.1 Global Opioid Induced Constipation (OIC) Drugs Sales Breakdown in Volume, by Application (2022-2027)
4.2.3.2 Global Opioid Induced Constipation (OIC) Drugs Sales Breakdown in Value, by Application (2022-2027)
4.2.3.3 Global Opioid Induced Constipation (OIC) Drugs Average Selling Price (ASP) by Application (2022-2027)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Opioid Induced Constipation (OIC) Drugs Sales Breakdown by Application (2016-2021)
4.3.2 Europe Opioid Induced Constipation (OIC) Drugs Sales Breakdown by Application (2016-2021)
4.3.3 Asia-Pacific Opioid Induced Constipation (OIC) Drugs Sales Breakdown by Application (2016-2021)
4.3.4 Latin America Opioid Induced Constipation (OIC) Drugs Sales Breakdown by Application (2016-2021)
4.3.5 Middle East and Africa Opioid Induced Constipation (OIC) Drugs Sales Breakdown by Application (2016-2021)
5 North America Opioid Induced Constipation (OIC) Drugs by Country
5.1 North America Opioid Induced Constipation (OIC) Drugs Historic Market Size by Country
5.1.1 North America Opioid Induced Constipation (OIC) Drugs Sales in Volume by Country (2016-2021)
5.1.2 North America Opioid Induced Constipation (OIC) Drugs Sales in Value by Country (2016-2021)
5.2 North America Opioid Induced Constipation (OIC) Drugs Forecasted Market Size by Country
5.2.1 North America Opioid Induced Constipation (OIC) Drugs Sales in Volume by Country (2022-2027)
5.2.2 North America Opioid Induced Constipation (OIC) Drugs Sales in Value by Country (2022-2027)
6 Europe Opioid Induced Constipation (OIC) Drugs by Country
6.1 Europe Opioid Induced Constipation (OIC) Drugs Historic Market Size by Country
6.1.1 Europe Opioid Induced Constipation (OIC) Drugs Sales in Volume by Country (2016-2021)
6.1.2 Europe Opioid Induced Constipation (OIC) Drugs Sales in Value by Country (2016-2021)
6.2 Europe Opioid Induced Constipation (OIC) Drugs Forecasted Market Size by Country
6.2.1 Europe Opioid Induced Constipation (OIC) Drugs Sales in Volume by Country (2022-2027)
6.2.2 Europe Opioid Induced Constipation (OIC) Drugs Sales in Value by Country (2022-2027)
7 Asia-Pacific Opioid Induced Constipation (OIC) Drugs by Region
7.1 Asia-Pacific Opioid Induced Constipation (OIC) Drugs Historic Market Size by Region
7.1.1 Asia-Pacific Opioid Induced Constipation (OIC) Drugs Sales in Volume by Region (2016-2021)
7.1.2 Asia-Pacific Opioid Induced Constipation (OIC) Drugs Sales in Value by Region (2016-2021)
7.2 Asia-Pacific Opioid Induced Constipation (OIC) Drugs Forecasted Market Size by Region
7.2.1 Asia-Pacific Opioid Induced Constipation (OIC) Drugs Sales in Volume by Region (2022-2027)
7.2.2 Asia-Pacific Opioid Induced Constipation (OIC) Drugs Sales in Value by Region (2022-2027)
8 Latin America Opioid Induced Constipation (OIC) Drugs by Country
8.1 Latin America Opioid Induced Constipation (OIC) Drugs Historic Market Size by Country
8.1.1 Latin America Opioid Induced Constipation (OIC) Drugs Sales in Volume by Country (2016-2021)
8.1.2 Latin America Opioid Induced Constipation (OIC) Drugs Sales in Value by Country (2016-2021)
8.2 Latin America Opioid Induced Constipation (OIC) Drugs Forecasted Market Size by Country
8.2.1 Latin America Opioid Induced Constipation (OIC) Drugs Sales in Volume by Country (2022-2027)
8.2.2 Latin America Opioid Induced Constipation (OIC) Drugs Sales in Value by Country (2022-2027)
9 Middle East and Africa Opioid Induced Constipation (OIC) Drugs by Country
9.1 Middle East and Africa Opioid Induced Constipation (OIC) Drugs Historic Market Size by Country
9.1.1 Middle East and Africa Opioid Induced Constipation (OIC) Drugs Sales in Volume by Country (2016-2021)
9.1.2 Middle East and Africa Opioid Induced Constipation (OIC) Drugs Sales in Value by Country (2016-2021)
9.2 Middle East and Africa Opioid Induced Constipation (OIC) Drugs Forecasted Market Size by Country
9.2.1 Middle East and Africa Opioid Induced Constipation (OIC) Drugs Sales in Volume by Country (2022-2027)
9.2.2 Middle East and Africa Opioid Induced Constipation (OIC) Drugs Sales in Value by Country (2022-2027)
10 Company Profiles and Key Figures in Opioid Induced Constipation (OIC) Drugs Business
10.1 Ironwood Pharmaceuticals Inc
10.1.1 Ironwood Pharmaceuticals Inc Corporation Information
10.1.2 Ironwood Pharmaceuticals Inc Introduction and Business Overview
10.1.3 Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2016-2021)
10.1.4 Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Products Offered
10.1.5 Ironwood Pharmaceuticals Inc Recent Development
10.2 Daiichi Sankyo Co Ltd
10.2.1 Daiichi Sankyo Co Ltd Corporation Information
10.2.2 Daiichi Sankyo Co Ltd Introduction and Business Overview
10.2.3 Daiichi Sankyo Co Ltd Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2016-2021)
10.2.4 Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Products Offered
10.2.5 Daiichi Sankyo Co Ltd Recent Development
10.3 Pfizer
10.3.1 Pfizer Corporation Information
10.3.2 Pfizer Introduction and Business Overview
10.3.3 Pfizer Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2016-2021)
10.3.4 Pfizer Opioid Induced Constipation (OIC) Drugs Products Offered
10.3.5 Pfizer Recent Development
10.4 Progenics Pharmaceuticals Inc
10.4.1 Progenics Pharmaceuticals Inc Corporation Information
10.4.2 Progenics Pharmaceuticals Inc Introduction and Business Overview
10.4.3 Progenics Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2016-2021)
10.4.4 Progenics Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Products Offered
10.4.5 Progenics Pharmaceuticals Inc Recent Development
10.5 Shionogi & Co., Ltd
10.5.1 Shionogi & Co., Ltd Corporation Information
10.5.2 Shionogi & Co., Ltd Introduction and Business Overview
10.5.3 Shionogi & Co., Ltd Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2016-2021)
10.5.4 Shionogi & Co., Ltd Opioid Induced Constipation (OIC) Drugs Products Offered
10.5.5 Shionogi & Co., Ltd Recent Development
10.6 Allergan Plc
10.6.1 Allergan Plc Corporation Information
10.6.2 Allergan Plc Introduction and Business Overview
10.6.3 Allergan Plc Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2016-2021)
10.6.4 Allergan Plc Opioid Induced Constipation (OIC) Drugs Products Offered
10.6.5 Allergan Plc Recent Development
10.7 Nektar Therapeutics
10.7.1 Nektar Therapeutics Corporation Information
10.7.2 Nektar Therapeutics Introduction and Business Overview
10.7.3 Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2016-2021)
10.7.4 Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Products Offered
10.7.5 Nektar Therapeutics Recent Development
10.8 Purdue Pharma
10.8.1 Purdue Pharma Corporation Information
10.8.2 Purdue Pharma Introduction and Business Overview
10.8.3 Purdue Pharma Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2016-2021)
10.8.4 Purdue Pharma Opioid Induced Constipation (OIC) Drugs Products Offered
10.8.5 Purdue Pharma Recent Development
10.9 S.L.A. Pharma AG
10.9.1 S.L.A. Pharma AG Corporation Information
10.9.2 S.L.A. Pharma AG Introduction and Business Overview
10.9.3 S.L.A. Pharma AG Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2016-2021)
10.9.4 S.L.A. Pharma AG Opioid Induced Constipation (OIC) Drugs Products Offered
10.9.5 S.L.A. Pharma AG Recent Development
10.10 Mundipharma International Limited
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Opioid Induced Constipation (OIC) Drugs Product Category, Application and Specification
10.10.3 Mundipharma International Limited Opioid Induced Constipation (OIC) Drugs Sales, Revenue, Price and Gross Margin (2016-2021)
10.10.4 Main Business Overview
10.10.5 Mundipharma International Limited Recent Development
10.11 Ono Pharmaceutical Co., Ltd
10.11.1 Ono Pharmaceutical Co., Ltd Corporation Information
10.11.2 Ono Pharmaceutical Co., Ltd Introduction and Business Overview
10.11.3 Ono Pharmaceutical Co., Ltd Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2016-2021)
10.11.4 Ono Pharmaceutical Co., Ltd Opioid Induced Constipation (OIC) Drugs Products Offered
10.11.5 Ono Pharmaceutical Co., Ltd Recent Development
10.12 Takeda Pharmaceutical Company Limited
10.12.1 Takeda Pharmaceutical Company Limited Corporation Information
10.12.2 Takeda Pharmaceutical Company Limited Introduction and Business Overview
10.12.3 Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2016-2021)
10.12.4 Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drugs Products Offered
10.12.5 Takeda Pharmaceutical Company Limited Recent Development
10.13 Theravance Biopharma Inc
10.13.1 Theravance Biopharma Inc Corporation Information
10.13.2 Theravance Biopharma Inc Introduction and Business Overview
10.13.3 Theravance Biopharma Inc Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2016-2021)
10.13.4 Theravance Biopharma Inc Opioid Induced Constipation (OIC) Drugs Products Offered
10.13.5 Theravance Biopharma Inc Recent Development
10.14 Bausch Health
10.14.1 Bausch Health Corporation Information
10.14.2 Bausch Health Introduction and Business Overview
10.14.3 Bausch Health Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2016-2021)
10.14.4 Bausch Health Opioid Induced Constipation (OIC) Drugs Products Offered
10.14.5 Bausch Health Recent Development
10.15 Cosmo Pharmaceuticals SA
10.15.1 Cosmo Pharmaceuticals SA Corporation Information
10.15.2 Cosmo Pharmaceuticals SA Introduction and Business Overview
10.15.3 Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2016-2021)
10.15.4 Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drugs Products Offered
10.15.5 Cosmo Pharmaceuticals SA Recent Development
10.16 Daewoong Pharmaceutical
10.16.1 Daewoong Pharmaceutical Corporation Information
10.16.2 Daewoong Pharmaceutical Introduction and Business Overview
10.16.3 Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2016-2021)
10.16.4 Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drugs Products Offered
10.16.5 Daewoong Pharmaceutical Recent Development
10.17 C.B. Fleet Company
10.17.1 C.B. Fleet Company Corporation Information
10.17.2 C.B. Fleet Company Introduction and Business Overview
10.17.3 C.B. Fleet Company Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2016-2021)
10.17.4 C.B. Fleet Company Opioid Induced Constipation (OIC) Drugs Products Offered
10.17.5 C.B. Fleet Company Recent Development
10.18 Sucampo Pharmaceuticals
10.18.1 Sucampo Pharmaceuticals Corporation Information
10.18.2 Sucampo Pharmaceuticals Introduction and Business Overview
10.18.3 Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2016-2021)
10.18.4 Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drugs Products Offered
10.18.5 Sucampo Pharmaceuticals Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Opioid Induced Constipation (OIC) Drugs Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Opioid Induced Constipation (OIC) Drugs Industrial Chain Analysis
11.4 Opioid Induced Constipation (OIC) Drugs Market Dynamics
11.4.1 Industry Trends
11.4.2 Market Drivers
11.4.3 Market Challenges
11.4.4 Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Opioid Induced Constipation (OIC) Drugs Distributors
12.3 Opioid Induced Constipation (OIC) Drugs Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
1.1 Opioid Induced Constipation (OIC) Drugs Product Overview
1.2 Opioid Induced Constipation (OIC) Drugs Market Segment by Type
1.2.1 Lubiprostone
1.2.2 Methyl Naltrexone Bromide
1.2.3 Naldemedine
1.2.4 Alvimopan
1.2.5 Others
1.3 Global Opioid Induced Constipation (OIC) Drugs Market Size by Type
1.3.1 Global Opioid Induced Constipation (OIC) Drugs Market Size Overview by Type (2016-2027)
1.3.2 Global Opioid Induced Constipation (OIC) Drugs Historic Market Size Review by Type (2016-2021)
1.3.2.1 Global Opioid Induced Constipation (OIC) Drugs Sales Breakdown in Volume by Type (2016-2021)
1.3.2.2 Global Opioid Induced Constipation (OIC) Drugs Sales Breakdown in Value by Type (2016-2021)
1.3.2.3 Global Opioid Induced Constipation (OIC) Drugs Average Selling Price (ASP) by Type (2016-2021)
1.3.3 Global Opioid Induced Constipation (OIC) Drugs Forecasted Market Size by Type (2022-2027)
1.3.3.1 Global Opioid Induced Constipation (OIC) Drugs Sales Breakdown in Volume by Type (2022-2027)
1.3.3.2 Global Opioid Induced Constipation (OIC) Drugs Sales Breakdown in Value by Type (2022-2027)
1.3.3.3 Global Opioid Induced Constipation (OIC) Drugs Average Selling Price (ASP) by Type (2022-2027)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Opioid Induced Constipation (OIC) Drugs Sales Breakdown by Type (2016-2021)
1.4.2 Europe Opioid Induced Constipation (OIC) Drugs Sales Breakdown by Type (2016-2021)
1.4.3 Asia-Pacific Opioid Induced Constipation (OIC) Drugs Sales Breakdown by Type (2016-2021)
1.4.4 Latin America Opioid Induced Constipation (OIC) Drugs Sales Breakdown by Type (2016-2021)
1.4.5 Middle East and Africa Opioid Induced Constipation (OIC) Drugs Sales Breakdown by Type (2016-2021)
2 Global Opioid Induced Constipation (OIC) Drugs Market Competition by Company
2.1 Global Top Players by Opioid Induced Constipation (OIC) Drugs Sales (2016-2021)
2.2 Global Top Players by Opioid Induced Constipation (OIC) Drugs Revenue (2016-2021)
2.3 Global Top Players Opioid Induced Constipation (OIC) Drugs Price (2016-2021)
2.4 Global Top Manufacturers Opioid Induced Constipation (OIC) Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Opioid Induced Constipation (OIC) Drugs Market Competitive Situation and Trends
2.5.1 Opioid Induced Constipation (OIC) Drugs Market Concentration Rate (2016-2021)
2.5.2 Global 5 and 10 Largest Manufacturers by Opioid Induced Constipation (OIC) Drugs Sales and Revenue in 2020
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Opioid Induced Constipation (OIC) Drugs as of 2020)
2.7 Date of Key Manufacturers Enter into Opioid Induced Constipation (OIC) Drugs Market
2.8 Key Manufacturers Opioid Induced Constipation (OIC) Drugs Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Opioid Induced Constipation (OIC) Drugs Status and Outlook by Region
3.1 Global Opioid Induced Constipation (OIC) Drugs Market Size and CAGR by Region: 2016 VS 2021 VS 2026
3.2 Global Opioid Induced Constipation (OIC) Drugs Historic Market Size by Region
3.2.1 Global Opioid Induced Constipation (OIC) Drugs Sales in Volume by Region (2016-2021)
3.2.2 Global Opioid Induced Constipation (OIC) Drugs Sales in Value by Region (2016-2021)
3.2.3 Global Opioid Induced Constipation (OIC) Drugs Sales (Volume & Value) Price and Gross Margin (2016-2021)
3.3 Global Opioid Induced Constipation (OIC) Drugs Forecasted Market Size by Region
3.3.1 Global Opioid Induced Constipation (OIC) Drugs Sales in Volume by Region (2022-2027)
3.3.2 Global Opioid Induced Constipation (OIC) Drugs Sales in Value by Region (2022-2027)
3.3.3 Global Opioid Induced Constipation (OIC) Drugs Sales (Volume & Value), Price and Gross Margin (2022-2027)
4 Global Opioid Induced Constipation (OIC) Drugs by Application
4.1 Opioid Induced Constipation (OIC) Drugs Market Segment by Application
4.1.1 Hospital Pharmacies
4.1.2 Retail Pharmacies
4.1.3 Online Pharmacies
4.2 Global Opioid Induced Constipation (OIC) Drugs Market Size by Application
4.2.1 Global Opioid Induced Constipation (OIC) Drugs Market Size Overview by Application (2016-2027)
4.2.2 Global Opioid Induced Constipation (OIC) Drugs Historic Market Size Review by Application (2016-2021)
4.2.2.1 Global Opioid Induced Constipation (OIC) Drugs Sales Breakdown in Volume, by Application (2016-2021)
4.2.2.2 Global Opioid Induced Constipation (OIC) Drugs Sales Breakdown in Value, by Application (2016-2021)
4.2.2.3 Global Opioid Induced Constipation (OIC) Drugs Average Selling Price (ASP) by Application (2016-2021)
4.2.3 Global Opioid Induced Constipation (OIC) Drugs Forecasted Market Size by Application (2022-2027)
4.2.3.1 Global Opioid Induced Constipation (OIC) Drugs Sales Breakdown in Volume, by Application (2022-2027)
4.2.3.2 Global Opioid Induced Constipation (OIC) Drugs Sales Breakdown in Value, by Application (2022-2027)
4.2.3.3 Global Opioid Induced Constipation (OIC) Drugs Average Selling Price (ASP) by Application (2022-2027)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Opioid Induced Constipation (OIC) Drugs Sales Breakdown by Application (2016-2021)
4.3.2 Europe Opioid Induced Constipation (OIC) Drugs Sales Breakdown by Application (2016-2021)
4.3.3 Asia-Pacific Opioid Induced Constipation (OIC) Drugs Sales Breakdown by Application (2016-2021)
4.3.4 Latin America Opioid Induced Constipation (OIC) Drugs Sales Breakdown by Application (2016-2021)
4.3.5 Middle East and Africa Opioid Induced Constipation (OIC) Drugs Sales Breakdown by Application (2016-2021)
5 North America Opioid Induced Constipation (OIC) Drugs by Country
5.1 North America Opioid Induced Constipation (OIC) Drugs Historic Market Size by Country
5.1.1 North America Opioid Induced Constipation (OIC) Drugs Sales in Volume by Country (2016-2021)
5.1.2 North America Opioid Induced Constipation (OIC) Drugs Sales in Value by Country (2016-2021)
5.2 North America Opioid Induced Constipation (OIC) Drugs Forecasted Market Size by Country
5.2.1 North America Opioid Induced Constipation (OIC) Drugs Sales in Volume by Country (2022-2027)
5.2.2 North America Opioid Induced Constipation (OIC) Drugs Sales in Value by Country (2022-2027)
6 Europe Opioid Induced Constipation (OIC) Drugs by Country
6.1 Europe Opioid Induced Constipation (OIC) Drugs Historic Market Size by Country
6.1.1 Europe Opioid Induced Constipation (OIC) Drugs Sales in Volume by Country (2016-2021)
6.1.2 Europe Opioid Induced Constipation (OIC) Drugs Sales in Value by Country (2016-2021)
6.2 Europe Opioid Induced Constipation (OIC) Drugs Forecasted Market Size by Country
6.2.1 Europe Opioid Induced Constipation (OIC) Drugs Sales in Volume by Country (2022-2027)
6.2.2 Europe Opioid Induced Constipation (OIC) Drugs Sales in Value by Country (2022-2027)
7 Asia-Pacific Opioid Induced Constipation (OIC) Drugs by Region
7.1 Asia-Pacific Opioid Induced Constipation (OIC) Drugs Historic Market Size by Region
7.1.1 Asia-Pacific Opioid Induced Constipation (OIC) Drugs Sales in Volume by Region (2016-2021)
7.1.2 Asia-Pacific Opioid Induced Constipation (OIC) Drugs Sales in Value by Region (2016-2021)
7.2 Asia-Pacific Opioid Induced Constipation (OIC) Drugs Forecasted Market Size by Region
7.2.1 Asia-Pacific Opioid Induced Constipation (OIC) Drugs Sales in Volume by Region (2022-2027)
7.2.2 Asia-Pacific Opioid Induced Constipation (OIC) Drugs Sales in Value by Region (2022-2027)
8 Latin America Opioid Induced Constipation (OIC) Drugs by Country
8.1 Latin America Opioid Induced Constipation (OIC) Drugs Historic Market Size by Country
8.1.1 Latin America Opioid Induced Constipation (OIC) Drugs Sales in Volume by Country (2016-2021)
8.1.2 Latin America Opioid Induced Constipation (OIC) Drugs Sales in Value by Country (2016-2021)
8.2 Latin America Opioid Induced Constipation (OIC) Drugs Forecasted Market Size by Country
8.2.1 Latin America Opioid Induced Constipation (OIC) Drugs Sales in Volume by Country (2022-2027)
8.2.2 Latin America Opioid Induced Constipation (OIC) Drugs Sales in Value by Country (2022-2027)
9 Middle East and Africa Opioid Induced Constipation (OIC) Drugs by Country
9.1 Middle East and Africa Opioid Induced Constipation (OIC) Drugs Historic Market Size by Country
9.1.1 Middle East and Africa Opioid Induced Constipation (OIC) Drugs Sales in Volume by Country (2016-2021)
9.1.2 Middle East and Africa Opioid Induced Constipation (OIC) Drugs Sales in Value by Country (2016-2021)
9.2 Middle East and Africa Opioid Induced Constipation (OIC) Drugs Forecasted Market Size by Country
9.2.1 Middle East and Africa Opioid Induced Constipation (OIC) Drugs Sales in Volume by Country (2022-2027)
9.2.2 Middle East and Africa Opioid Induced Constipation (OIC) Drugs Sales in Value by Country (2022-2027)
10 Company Profiles and Key Figures in Opioid Induced Constipation (OIC) Drugs Business
10.1 Ironwood Pharmaceuticals Inc
10.1.1 Ironwood Pharmaceuticals Inc Corporation Information
10.1.2 Ironwood Pharmaceuticals Inc Introduction and Business Overview
10.1.3 Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2016-2021)
10.1.4 Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Products Offered
10.1.5 Ironwood Pharmaceuticals Inc Recent Development
10.2 Daiichi Sankyo Co Ltd
10.2.1 Daiichi Sankyo Co Ltd Corporation Information
10.2.2 Daiichi Sankyo Co Ltd Introduction and Business Overview
10.2.3 Daiichi Sankyo Co Ltd Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2016-2021)
10.2.4 Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Products Offered
10.2.5 Daiichi Sankyo Co Ltd Recent Development
10.3 Pfizer
10.3.1 Pfizer Corporation Information
10.3.2 Pfizer Introduction and Business Overview
10.3.3 Pfizer Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2016-2021)
10.3.4 Pfizer Opioid Induced Constipation (OIC) Drugs Products Offered
10.3.5 Pfizer Recent Development
10.4 Progenics Pharmaceuticals Inc
10.4.1 Progenics Pharmaceuticals Inc Corporation Information
10.4.2 Progenics Pharmaceuticals Inc Introduction and Business Overview
10.4.3 Progenics Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2016-2021)
10.4.4 Progenics Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Products Offered
10.4.5 Progenics Pharmaceuticals Inc Recent Development
10.5 Shionogi & Co., Ltd
10.5.1 Shionogi & Co., Ltd Corporation Information
10.5.2 Shionogi & Co., Ltd Introduction and Business Overview
10.5.3 Shionogi & Co., Ltd Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2016-2021)
10.5.4 Shionogi & Co., Ltd Opioid Induced Constipation (OIC) Drugs Products Offered
10.5.5 Shionogi & Co., Ltd Recent Development
10.6 Allergan Plc
10.6.1 Allergan Plc Corporation Information
10.6.2 Allergan Plc Introduction and Business Overview
10.6.3 Allergan Plc Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2016-2021)
10.6.4 Allergan Plc Opioid Induced Constipation (OIC) Drugs Products Offered
10.6.5 Allergan Plc Recent Development
10.7 Nektar Therapeutics
10.7.1 Nektar Therapeutics Corporation Information
10.7.2 Nektar Therapeutics Introduction and Business Overview
10.7.3 Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2016-2021)
10.7.4 Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Products Offered
10.7.5 Nektar Therapeutics Recent Development
10.8 Purdue Pharma
10.8.1 Purdue Pharma Corporation Information
10.8.2 Purdue Pharma Introduction and Business Overview
10.8.3 Purdue Pharma Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2016-2021)
10.8.4 Purdue Pharma Opioid Induced Constipation (OIC) Drugs Products Offered
10.8.5 Purdue Pharma Recent Development
10.9 S.L.A. Pharma AG
10.9.1 S.L.A. Pharma AG Corporation Information
10.9.2 S.L.A. Pharma AG Introduction and Business Overview
10.9.3 S.L.A. Pharma AG Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2016-2021)
10.9.4 S.L.A. Pharma AG Opioid Induced Constipation (OIC) Drugs Products Offered
10.9.5 S.L.A. Pharma AG Recent Development
10.10 Mundipharma International Limited
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Opioid Induced Constipation (OIC) Drugs Product Category, Application and Specification
10.10.3 Mundipharma International Limited Opioid Induced Constipation (OIC) Drugs Sales, Revenue, Price and Gross Margin (2016-2021)
10.10.4 Main Business Overview
10.10.5 Mundipharma International Limited Recent Development
10.11 Ono Pharmaceutical Co., Ltd
10.11.1 Ono Pharmaceutical Co., Ltd Corporation Information
10.11.2 Ono Pharmaceutical Co., Ltd Introduction and Business Overview
10.11.3 Ono Pharmaceutical Co., Ltd Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2016-2021)
10.11.4 Ono Pharmaceutical Co., Ltd Opioid Induced Constipation (OIC) Drugs Products Offered
10.11.5 Ono Pharmaceutical Co., Ltd Recent Development
10.12 Takeda Pharmaceutical Company Limited
10.12.1 Takeda Pharmaceutical Company Limited Corporation Information
10.12.2 Takeda Pharmaceutical Company Limited Introduction and Business Overview
10.12.3 Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2016-2021)
10.12.4 Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drugs Products Offered
10.12.5 Takeda Pharmaceutical Company Limited Recent Development
10.13 Theravance Biopharma Inc
10.13.1 Theravance Biopharma Inc Corporation Information
10.13.2 Theravance Biopharma Inc Introduction and Business Overview
10.13.3 Theravance Biopharma Inc Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2016-2021)
10.13.4 Theravance Biopharma Inc Opioid Induced Constipation (OIC) Drugs Products Offered
10.13.5 Theravance Biopharma Inc Recent Development
10.14 Bausch Health
10.14.1 Bausch Health Corporation Information
10.14.2 Bausch Health Introduction and Business Overview
10.14.3 Bausch Health Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2016-2021)
10.14.4 Bausch Health Opioid Induced Constipation (OIC) Drugs Products Offered
10.14.5 Bausch Health Recent Development
10.15 Cosmo Pharmaceuticals SA
10.15.1 Cosmo Pharmaceuticals SA Corporation Information
10.15.2 Cosmo Pharmaceuticals SA Introduction and Business Overview
10.15.3 Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2016-2021)
10.15.4 Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drugs Products Offered
10.15.5 Cosmo Pharmaceuticals SA Recent Development
10.16 Daewoong Pharmaceutical
10.16.1 Daewoong Pharmaceutical Corporation Information
10.16.2 Daewoong Pharmaceutical Introduction and Business Overview
10.16.3 Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2016-2021)
10.16.4 Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drugs Products Offered
10.16.5 Daewoong Pharmaceutical Recent Development
10.17 C.B. Fleet Company
10.17.1 C.B. Fleet Company Corporation Information
10.17.2 C.B. Fleet Company Introduction and Business Overview
10.17.3 C.B. Fleet Company Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2016-2021)
10.17.4 C.B. Fleet Company Opioid Induced Constipation (OIC) Drugs Products Offered
10.17.5 C.B. Fleet Company Recent Development
10.18 Sucampo Pharmaceuticals
10.18.1 Sucampo Pharmaceuticals Corporation Information
10.18.2 Sucampo Pharmaceuticals Introduction and Business Overview
10.18.3 Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2016-2021)
10.18.4 Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drugs Products Offered
10.18.5 Sucampo Pharmaceuticals Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Opioid Induced Constipation (OIC) Drugs Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Opioid Induced Constipation (OIC) Drugs Industrial Chain Analysis
11.4 Opioid Induced Constipation (OIC) Drugs Market Dynamics
11.4.1 Industry Trends
11.4.2 Market Drivers
11.4.3 Market Challenges
11.4.4 Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Opioid Induced Constipation (OIC) Drugs Distributors
12.3 Opioid Induced Constipation (OIC) Drugs Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
